Compass Therapeutics logo

Compass Therapeutics

CMPX | NASDAQ
Chart Builder DCF Calculator
$0.66
-$0.11 (-14.71%)
At close: Nov 16, 2026, 4:00 PM ET
$0.70
+$0.04 (+6.38%)
After-hours: Nov 16, 2026, 7:27 PM ET
-14.71%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
17.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1007/1021 (Top 99%)

Key Statistics

Market Data

Market Cap $119.13M
1D Range
0.66 0.78
52W Range
0.66 6.69

Valuation (TTM)

PE -1.43
PB 0.84
EV/EBITDA 0.41

Valuation (NTM)

Forward PE N/A
Forward PEG -0.08
Price Target $4.00
Loading financial charts...

Profile

Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating a...

Sector Healthcare
Industry Biotechnology
Employees 39
IPO Date Apr 5, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
8
Consensus
Buy
Price Target
$4.00
Upside
+506.06%
Buy (7)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.